CAMBRIDGE, Mass. and SAN DIEGO, Calif., Dec. 5 /PRNewswire-FirstCall/--
Biogen Idec Inc. (Nasdaq: BIIB) announced today that its analyst discussion of
Biogen Idec related abstracts at the American Society of Hematology (ASH) will
be webcast live on Saturday, December 6, 2003. The live webcast begins at
10:00 am (ET) and is accessible through Biogen Idec's website,
http://www.BiogenIdec.com.
(Logo: http://www.newscom.com/cgi-bin/prnh/20031112/LAW121LOGO )
About Biogen Idec
Biogen Idec creates new standards of care in oncology and immunology. As a
global leader in the development, manufacturing, and commercialization of
novel therapies, Biogen IDEC transforms scientific discoveries into advances
in human healthcare. For product labeling, press releases and additional
information about the company, please visit http://www.biogenidec.com.
Contact:
Rob Jacobson
Investor Relations Specialist
Biogen Idec Inc.
Rob.Jacobson@BiogenIdec.com
617/679-3710
SOURCE Biogen Idec Inc.
 back to top
Related links:
http://www.BiogenIdec.com
Company News On-Call:
http://www.prnewswire.com/comp/101550.html
Photo Notes:http://www.newscom.com/cgi-bin/prnh/20031112/LAW121LOGO
AP Archive: http://photoarchive.ap.org
PRN Photo Desk, 888-776-6555 or 212-782-2840
CONTACT:
Rob Jacobson, Investor Relations Specialist
of Biogen Idec Inc., +1-617-679-3710, Rob.Jacobson@BiogenIdec.com
|
